Philip Wenzel Selected Research

Philip Wenzel Research Topics

Disease

29	Inflammation (Inflammations) 11/2022 - 03/2011
21	Hypertension (High Blood Pressure) 01/2020 - 10/2006
10	Thrombosis (Thrombus) 12/2021 - 11/2013
9	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 12/2014
9	Myocardial Infarction 03/2021 - 07/2009
8	Cardiovascular Diseases (Cardiovascular Disease) 07/2020 - 07/2009
7	Skin Diseases (Skin Disease) 11/2022 - 12/2014
7	Heart Failure 03/2021 - 08/2007
7	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 01/2014
6	Fibrosis (Cirrhosis) 01/2020 - 02/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2009
5	Diabetes Mellitus 12/2015 - 05/2008
4	Cardiotoxicity 01/2020 - 08/2007
4	Atherosclerosis 01/2020 - 11/2013
4	Body Weight (Weight, Body) 01/2017 - 09/2008
3	Neoplasms (Cancer) 01/2022 - 09/2020
3	Hemorrhage 01/2022 - 01/2017
3	Myocarditis (Carditis) 01/2022 - 08/2007
3	Acute Coronary Syndrome 11/2020 - 01/2014
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 02/2015
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 08/2007
3	Vascular Diseases (Vascular Disease) 01/2019 - 11/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014 - 11/2011
2	Chest Pain (Chest Pains) 01/2021 - 11/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 10/2017
2	Necrosis 11/2019 - 12/2018
2	Pulmonary Hypertension 08/2019 - 01/2017
2	Pulmonary Embolism 08/2019 - 01/2018
2	Alcoholic Cardiomyopathy 01/2018 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 10/2017 - 11/2006
2	Ischemia 07/2015 - 04/2011
2	Hyperglycemia 01/2014 - 10/2011
2	Vascular System Injuries 01/2014 - 09/2008
2	Infarction (Infarctions) 04/2011 - 07/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2011 - 09/2008
1	Hypertrophy 10/2022
1	Muscular Diseases (Myopathy) 10/2022

Drug/Important Bio-Agent (IBA)

21	Angiotensin IIIBA 10/2022 - 10/2006
10	CytokinesIBA 01/2020 - 08/2007
9	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2017 - 11/2006
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018 - 10/2006
7	NitratesIBA 11/2015 - 08/2008
6	Superoxides (Superoxide)IBA 03/2021 - 12/2005
5	Messenger RNA (mRNA)IBA 06/2022 - 02/2015
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 12/2014
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2014
5	NitrogenIBA 01/2017 - 01/2011
5	Oxygen (Dioxygen)IBA 01/2017 - 01/2011
5	EnzymesIBA 02/2014 - 09/2008
4	Thrombin FDA Link 09/2020 - 01/2017
4	Muramidase (Lysozyme)IBA 11/2019 - 09/2011
4	ChemokinesIBA 01/2019 - 08/2007
4	Pentaerythritol Tetranitrate (Pentalog)IBA 01/2017 - 02/2010
4	Heme Oxygenase-1IBA 12/2015 - 08/2010
4	Streptozocin (Streptozotocin)FDA Link 12/2015 - 05/2008
4	AntioxidantsIBA 01/2014 - 09/2008
4	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2009 - 11/2006
3	Imiquimod (Aldara)FDA LinkGeneric 11/2022 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2015
3	Interferon-gamma (Interferon, gamma)IBA 11/2019 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2006
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2014
3	Interleukin-12 (IL 12)IBA 01/2018 - 08/2007
3	InterferonsIBA 12/2016 - 08/2007
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 08/2019
2	AnticoagulantsIBA 09/2020 - 01/2017
2	Liraglutide FDA Link 01/2020 - 01/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2017
2	InterleukinsIBA 08/2019 - 12/2014
2	Telmisartan (Micardis)FDA Link 08/2019 - 09/2008
2	FibrinIBA 01/2019 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2015
2	AcetaldehydeIBA 01/2018 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 10/2012
2	Thromboplastin (Tissue Factor)IBA 01/2017 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2016
2	LinagliptinIBA 01/2017 - 10/2012
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 09/2011
2	Peroxidase (Myeloperoxidase)IBA 07/2015 - 12/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2014 - 11/2006
2	IvabradineIBA 11/2011 - 10/2009
2	acetovanillone (apocynin)IBA 03/2011 - 01/2011
2	Blood Glucose (Blood Sugar)IBA 01/2011 - 09/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2011 - 04/2009
2	Atorvastatin (Lipitor)FDA Link 07/2009 - 05/2008
1	CalnexinIBA 10/2022
1	Beclin-1IBA 10/2022
1	ursodoxicoltaurineIBA 10/2022
1	Mitochondrial Permeability Transition PoreIBA 10/2022
1	Hormones (Hormone)IBA 10/2022
1	CalciumIBA 10/2022
1	VaccinesIBA 06/2022

Therapy/Procedure

7	Therapeutics 09/2020 - 09/2008
6	Ligation 12/2021 - 01/2014
3	Percutaneous Coronary Intervention 01/2020 - 11/2017
3	Stents 11/2017 - 01/2014